Your search returned 97 studies. (Get alerts for new studies):
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Childhood Chronic Myelogenous Leukemia - Chronic Myelogen
5 Locations available
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Prima
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome
5 Locations available
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
1 Location available
- PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia
2 Locations available
- Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Male and Female Subjects, Greater Than 60 Years of Age With Non-M3 AML
1 Location available
- Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adu
1 Location available
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
2 Locations available
- Unrelated Donor Stem Cell Transplantation
Conditions: Severe Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndromes - Myeloproliferative Syndromes - Chronic Myelogenous Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphom
1 Location available
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma - Burkitts Leukemia/Lymphoma - Chronic Myelogenous Leukemia
1 Location available
- Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients Wit
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
1 Location available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Sitagliptin Umbilical Cord Blood Transplant Study
Conditions: Leukemia, Myeloid, Acute - Acute Lymphoblastic Leukemia - Myelodysplasia - Leukemia, Myelogenous, Chronic - Lymphoma, Non-Hodgkin
1 Location available
- Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leuke
Conditions: Acute Myelogenous Leukemia - Diffuse Large B-Cell Leukemia - Chronic Lymphocytic Leukemia - Follicular Lymphoma
6 Locations available
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - High-risk Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Advanced Myelofibrosis
1 Location available
- Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Conditions: Pediatric Acute Myelogenous Leukemia (AML)
15 Locations available
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Don
Conditions: Hematopoietic/Lymphoid Cancer - Accelerated Phase Chronic Myelogenous Leukemia - Acute Undifferentiated Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL)
1 Location available
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in P
Conditions: Acute Myelogenous Leukemia (AML)
5 Locations available
- Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Mantle
1 Location available
- A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenal
Conditions: Acute Myeloid Leukemia - Acute Myelogenous Leukemia
8 Locations available
- Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute M
1 Location available
- Fludarabine Phosphate and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Chronic Phase Chronic Myelogenous Leukemia - Philadelphi
3 Locations available
- Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;
2 Locations available
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leuk
3 Locations available
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Conditions: Chronic Myelogenous Leukemia - Acute Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome
1 Location available
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
3 Locations available
- Targeted, Dose-Escalated Intravenous Busulfan and Bolus Etoposide as Preparative Therapy for Patients With Acute Myeloid Leukemia Undergoing Autologou
Conditions: Acute Myelogenous Leukemia
1 Location available
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - AIDS-related Diffuse Large Cell Lymphoma - AIDS-related Diffuse
1 Location available
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Conditions: Leukemia, Myelogenous, Acute - Myelodysplastic Syndromes
1 Location available
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - B-cell Chronic Lymphocytic Leukemia - Myelodysplasia
2 Locations available
- HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Tr
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Multiple Myeloma
1 Location available
- Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Conditions: AML
2 Locations available
- Reduced Intensity Double Umbilical Cord Blood Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma - Chronic Lymphocytic Leukemia - Acute Myelogenous Leukemia
2 Locations available
- TL32711 in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- MRI Assessment of Leukemia Response to Therapy
Conditions: Acute Myelogenous Leukemia
1 Location available
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors - Malignant Melanoma - Hematological Malignancies - Myelogenous Leukemia, Chronic - Leukemia, Lymphoblastic, Acute
1 Location available
- Unrelated Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
5 Locations available
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Donor Umbilical Cord B
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
3 Locations available
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Conditions: Acute Myelogenous Leukemia - Leukemia
1 Location available
- Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Conditions: Minimal Residual Disease - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute
1 Location available
- AKT Kinase Inhibitor MK-2206 With Relapsed Refractory Acute Myelogenous Leukemia
Conditions: Leukemia
1 Location available
- Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hemato
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome
1 Location available
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Pati
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Undifferentiated Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myel
1 Location available
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute - Myeloproliferative-Myelodysplastic Diseases - Lymphoma, Malignant
1 Location available
- Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- Fludarabine, Cytarabine, Filgrastim and Idarubicin in Core Binding Factor (CBF) Leukemias
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
Conditions: Acute Leukemia - Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia - Biphenotypic Leukemia - Pre-leukemic Syndromes - Monosomy 7 - Bone Marrow Clonal Malformations - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndromes - Chronic Myelogenous Le
1 Location available
- 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Conditions: Leukemia
1 Location available
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acut
Conditions: Chronic Myeloid Leukemia - Acute Lymphoblastic Leukemia
1 Location available
- Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Conditions: Hematopoietic/Lymphoid Cancer - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myeloid Leukemia
2 Locations available
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Mye
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)
Conditions: Acute Myelogenous Leukemia (AML)
3 Locations available
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia
1 Location available
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Non-Hodgkins Lymphoma - Sarcoma - Neuroblastoma
5 Locations available
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leuk
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adu
3 Locations available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood - Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- PRO#1278: Fludarabin and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation
Conditions: Myeloid Malignancies - Acute Myelogenous Leukemia - Chronic Myelogenous Leukemia - Myeloproliferative Disorders - Myelodysplastic Syndrome
1 Location available
- Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Conditions: Acute Myeloid Leukemia
2 Locations available
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Conditions: Hematologic Diseases - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Conditions: Acute Lymphocytic Leukemia - Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- AHN-12 Biodistribution in Advanced Leukemia
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia
1 Location available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Lymphoblastic Leukemia in Remission - Adult
2 Locations available
- Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk
Conditions: Leukemia
1 Location available
- Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia
1 Location available
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Conditions: Double Cord Blood Transplant - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Myelofibrosis - Acute Lymphoblastic Leukemia - Chronic Myelocytic Leukemia - Non Hodgkins Lymphoma - Hodgkins Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome RAEB 1
2 Locations available
- Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
Conditions: Acute Myelogenous Leukemia
7 Locations available
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood
2 Locations available
- T-Cell Depleted Double UCB for Refractory AML
Conditions: Acute Myelogenous Leukemia - Refractory Acute Myelogenous Leukemia
1 Location available
- Administration of Donor T Cells With the Caspase-9 Suicide Gene
Conditions: Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome - Acute Myeloid Leukemia - Chronic Myelogenous Leukemia - Non Hodgkin Lymphoma - Hemophagocytic Lymphohistiocytosis - Familial Hemophagocytic Lymphohistiocytosis - Hemophagocytic Syndrome - Epstein B
2 Locations available
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Flu
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia
1 Location available
- A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoid - Myelodysplastic Syndromes - Leukemia, Myelogenous, Chronic
1 Location available
- Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
Conditions: Acute Myelogenous Leukemia - AML
1 Location available
- Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
1 Location available
- Selecting a Favorable KIR Donor in Unrelated HCT for AML
Conditions: Acute Myelogenous Leukemia
12 Locations available
- Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) Versus "7+3" for Newly (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Hodgkins Disease - Non-Hodgkins Lymphoma - Aplastic Anemia - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Conditions: Hematologic Malignancy - Leukemia - Acute Lymphoblastic Leukemia - ALL - Acute Myelogenous Leukemia - AML - Chronic Lymphocytic Leukemia - CLL - Lymphoma - Hodgkin's Lymphoma - Non-hodgkin's Lymphoma - Myeloma
1 Location available
|